Published in Am J Kidney Dis on October 30, 2010
Fibroblast growth factor 23 and risks of mortality and end-stage renal disease in patients with chronic kidney disease. JAMA (2011) 5.86
Effect of A Reduction in glomerular filtration rate after NEphrectomy on arterial STiffness and central hemodynamics: rationale and design of the EARNEST study. Am Heart J (2013) 2.07
Multicentre randomized controlled trial of angiotensin-converting enzyme inhibitor/angiotensin receptor blocker withdrawal in advanced renal disease: the STOP-ACEi trial. Nephrol Dial Transplant (2015) 1.42
Association of postoperative proteinuria with AKI after cardiac surgery among patients at high risk. Clin J Am Soc Nephrol (2012) 1.32
Risk models to predict chronic kidney disease and its progression: a systematic review. PLoS Med (2012) 1.25
Considerations in the optimal preparation of patients for dialysis. Nat Rev Nephrol (2012) 1.03
Fibroblast growth factor 23 and adverse clinical outcomes in chronic kidney disease. Curr Opin Nephrol Hypertens (2012) 1.01
Troponin elevation in conditions other than acute coronary syndromes. Vasc Health Risk Manag (2011) 1.01
Incorporating temporal EHR data in predictive models for risk stratification of renal function deterioration. J Biomed Inform (2014) 0.95
Predictors of high sensitivity cardiac troponin T in chronic kidney disease patients: a cross-sectional study in the chronic renal insufficiency cohort (CRIC). BMC Nephrol (2013) 0.94
Rationale and Approaches to Phosphate and Fibroblast Growth Factor 23 Reduction in CKD. J Am Soc Nephrol (2015) 0.92
Black-White differences in the effect of baseline depressive symptoms on deaths due to renal diseases: 25 year follow up of a nationally representative community sample. J Renal Inj Prev (2015) 0.92
Development and validation of a model to predict 5-year risk of death without ESRD among older adults with CKD. Clin J Am Soc Nephrol (2015) 0.90
Current and emerging treatment options for the elderly patient with chronic kidney disease. Clin Interv Aging (2014) 0.88
The natural history of, and risk factors for, progressive chronic kidney disease (CKD): the Renal Impairment in Secondary care (RIISC) study; rationale and protocol. BMC Nephrol (2013) 0.87
Serum free light chains and the risk of ESRD and death in CKD. Clin J Am Soc Nephrol (2011) 0.86
A simple tool to predict end-stage renal disease within 1 year in elderly adults with advanced chronic kidney disease. J Am Geriatr Soc (2013) 0.86
Effects of proactive population-based nephrologist oversight on progression of chronic kidney disease: a retrospective control analysis. BMC Health Serv Res (2012) 0.82
Chronic kidney disease prediction is an inexact science: The concept of "progressors" and "nonprogressors". World J Nephrol (2014) 0.81
Toward Big Data Analytics: Review of Predictive Models in Management of Diabetes and Its Complications. J Diabetes Sci Technol (2015) 0.81
Thromboxane prostanoid receptors enhance contractions, endothelin-1, and oxidative stress in microvessels from mice with chronic kidney disease. Hypertension (2015) 0.81
The next generation of therapeutics for chronic kidney disease. Nat Rev Drug Discov (2016) 0.79
Fibroblast growth factor 23 and incident CKD in type 2 diabetes. Clin J Am Soc Nephrol (2014) 0.79
Plasma levels of natriuretic peptides and development of chronic kidney disease. BMC Nephrol (2015) 0.77
Predicting mortality in older adults with kidney disease: a pragmatic prediction model. J Am Geriatr Soc (2015) 0.77
Mortality in dialysis patients may not be associated with ESA dose: a 2-year prospective observational study. BMC Nephrol (2012) 0.77
Epidemiologic trends in chronic renal replacement therapy over forty years: a Swiss dialysis experience. BMC Nephrol (2012) 0.76
Urine biomarkers of tubular injury do not improve on the clinical model predicting chronic kidney disease progression. Kidney Int (2016) 0.75
Chronic kidney disease: Does serum phosphate predict death and ESRD in CKD patients? Nat Rev Nephrol (2013) 0.75
Presence of early CKD-related metabolic complications predict progression of stage 3 CKD: a case-controlled study. BMC Nephrol (2014) 0.75
A Concept-Wide Association Study of Clinical Notes to Discover New Predictors of Kidney Failure. Clin J Am Soc Nephrol (2016) 0.75
First year survival of patients on maintenance dialysis treatment in Poland. Nagoya J Med Sci (2015) 0.75
Predicting death without dialysis in elderly patients with CKD. Clin J Am Soc Nephrol (2015) 0.75
Vascular access placement in patients with chronic kidney disease Stages 4 and 5 attending an inner city nephrology clinic: a cohort study and survey of providers. BMC Nephrol (2017) 0.75
Percutaneous Coronary Intervention Versus Optimal Medical Therapy for Stable Angina in Advanced CKD: A Decision Analysis. Am J Kidney Dis (2016) 0.75
The meaning and use of the area under a receiver operating characteristic (ROC) curve. Radiology (1982) 79.76
Prevalence of chronic kidney disease in the United States. JAMA (2007) 38.98
Longitudinal follow-up and outcomes among a population with chronic kidney disease in a large managed care organization. Arch Intern Med (2004) 7.79
Use of multiple biomarkers to improve the prediction of death from cardiovascular causes. N Engl J Med (2008) 7.33
Chronic kidney disease and mortality risk: a systematic review. J Am Soc Nephrol (2006) 6.21
Age affects outcomes in chronic kidney disease. J Am Soc Nephrol (2007) 5.36
Chronic kidney disease and the risk for cardiovascular disease, renal replacement, and death in the United States Medicare population, 1998 to 1999. J Am Soc Nephrol (2004) 4.79
How well does B-type natriuretic peptide predict death and cardiac events in patients with heart failure: systematic review. BMJ (2005) 4.31
Risk factors for end-stage renal disease: 25-year follow-up. Arch Intern Med (2009) 4.05
Chronic kidney disease management in the United Kingdom: NEOERICA project results. Kidney Int (2007) 3.76
Predictive value of cardiac troponin I and T for subsequent death in end-stage renal disease. Circulation (2002) 3.74
Clinical and echocardiographic disease in patients starting end-stage renal disease therapy. Kidney Int (1995) 3.70
Premature cardiovascular disease in chronic renal failure. Lancet (2000) 3.17
Variability and risk factors for kidney disease progression and death following attainment of stage 4 CKD in a referred cohort. Am J Kidney Dis (2008) 2.64
Risk scores for predicting outcomes in patients with type 2 diabetes and nephropathy: the RENAAL study. Clin J Am Soc Nephrol (2006) 2.37
Screening strategies for chronic kidney disease in the general population: follow-up of cross sectional health survey. BMJ (2006) 2.29
B-type natriuretic peptide (BNP) and amino-terminal proBNP in patients with CKD: relationship to renal function and left ventricular hypertrophy. Am J Kidney Dis (2005) 2.24
Multi-biomarker risk stratification of N-terminal pro-B-type natriuretic peptide, high-sensitivity C-reactive protein, and cardiac troponin T and I in end-stage renal disease for all-cause death. Clin Chem (2004) 2.01
Progression risk, urinary protein excretion, and treatment effects of angiotensin-converting enzyme inhibitors in nondiabetic kidney disease. J Am Soc Nephrol (2007) 2.00
The Framingham predictive instrument in chronic kidney disease. J Am Coll Cardiol (2007) 2.00
Inflammation, endothelial dysfunction, and platelet activation in patients with chronic kidney disease: the chronic renal impairment in Birmingham (CRIB) study. Am J Kidney Dis (2004) 1.76
Risk of incident ESRD: a comprehensive look at cardiovascular risk factors and 17 years of follow-up in the Atherosclerosis Risk in Communities (ARIC) Study. Am J Kidney Dis (2009) 1.74
Epidemiological evaluation of known and suspected cardiovascular risk factors in chronic renal impairment. Am J Kidney Dis (2001) 1.64
A scoring system to predict renal outcome in IgA nephropathy: from a nationwide prospective study. Nephrol Dial Transplant (2006) 1.64
Cardiac troponins and chronic kidney disease. Kidney Int (2006) 1.57
Predicting the risk of dialysis and transplant among patients with CKD: a retrospective cohort study. Am J Kidney Dis (2008) 1.54
Abnormalities of endothelial function in patients with predialysis renal failure. Heart (2000) 1.43
Renal risk scores: progress and prospects. Kidney Int (2008) 1.38
The horse-racing effect. Lancet (1981) 1.30
N-terminal pro-brain natriuretic peptide, but not high sensitivity C-reactive protein, improves cardiovascular risk prediction in the general population. Eur Heart J (2007) 1.30
N-terminal Pro-B-type natriuretic peptide, vascular disease risk, and cholesterol reduction among 20,536 patients in the MRC/BHF heart protection study. J Am Coll Cardiol (2007) 1.22
Cross-sectional analysis of abnormalities of mineral homeostasis, vitamin D and parathyroid hormone in a cohort of pre-dialysis patients. The chronic renal impairment in Birmingham (CRIB) study. Nephron Clin Pract (2007) 0.98
Prognostic value of cardiac biomarkers for death in a non-dialysis chronic kidney disease population. Nephrol Dial Transplant (2008) 0.96
Misleading associations between cholesterol and vascular outcomes in dialysis patients: the need for randomized trials. Semin Dial (2007) 0.86
Serum troponin T measurement in patients with chronic renal impairment predicts survival and vascular disease: a 2 year prospective study. Nephrol Dial Transplant (2003) 0.84
Elevated cardiac troponin T in predialysis patients is associated with inflammation and predicts mortality. J Intern Med (2003) 0.84
Aspirin in the primary and secondary prevention of vascular disease: collaborative meta-analysis of individual participant data from randomised trials. Lancet (2009) 13.64
Revascularization versus medical therapy for renal-artery stenosis. N Engl J Med (2009) 10.60
Effect of cinacalcet on cardiovascular disease in patients undergoing dialysis. N Engl J Med (2012) 8.88
Rituximab versus cyclophosphamide in ANCA-associated renal vasculitis. N Engl J Med (2010) 8.64
Comparison of risk prediction using the CKD-EPI equation and the MDRD study equation for estimated glomerular filtration rate. JAMA (2012) 6.26
Blood pressure-lowering treatment based on cardiovascular risk: a meta-analysis of individual patient data. Lancet (2014) 6.23
Aspirin in patients undergoing noncardiac surgery. N Engl J Med (2014) 6.10
Lower estimated glomerular filtration rate and higher albuminuria are associated with mortality and end-stage renal disease. A collaborative meta-analysis of kidney disease population cohorts. Kidney Int (2011) 5.25
Low-dose aspirin for the prevention of atherothrombosis. N Engl J Med (2005) 4.57
Alemtuzumab-based induction treatment versus basiliximab-based induction treatment in kidney transplantation (the 3C Study): a randomised trial. Lancet (2014) 4.05
New-onset diabetes after transplantation: 2003 International consensus guidelines. Proceedings of an international expert panel meeting. Barcelona, Spain, 19 February 2003. Transplantation (2003) 3.79
Efficacy and safety of LDL-lowering therapy among men and women: meta-analysis of individual data from 174,000 participants in 27 randomised trials. Lancet (2015) 3.79
British HIV Association Guidelines for the treatment of HIV-1-infected adults with antiretroviral therapy 2008. HIV Med (2008) 3.67
Passive smoking and risk of coronary heart disease and stroke: prospective study with cotinine measurement. BMJ (2004) 3.66
Analyses of cancer data from three ezetimibe trials. N Engl J Med (2008) 3.44
Effects of phosphate binders in moderate CKD. J Am Soc Nephrol (2012) 2.92
Serum iPTH, calcium and phosphate, and the risk of mortality in a European haemodialysis population. Nephrol Dial Transplant (2010) 2.70
Estimating equations for glomerular filtration rate in the era of creatinine standardization: a systematic review. Ann Intern Med (2012) 2.69
Cholesterol fractions and apolipoproteins as risk factors for heart disease mortality in older men. Arch Intern Med (2007) 2.55
Ensuring trial validity by data quality assurance and diversification of monitoring methods. Clin Trials (2008) 2.50
Cytomegalovirus glycoprotein-B vaccine with MF59 adjuvant in transplant recipients: a phase 2 randomised placebo-controlled trial. Lancet (2011) 2.50
Randomized clinical trials--removing unnecessary obstacles. N Engl J Med (2013) 2.43
New oral anticoagulants in atrial fibrillation and acute coronary syndromes: ESC Working Group on Thrombosis-Task Force on Anticoagulants in Heart Disease position paper. J Am Coll Cardiol (2012) 2.41
First United Kingdom Heart and Renal Protection (UK-HARP-I) study: biochemical efficacy and safety of simvastatin and safety of low-dose aspirin in chronic kidney disease. Am J Kidney Dis (2005) 2.36
Prospective study of ultraviolet radiation exposure and mortality risk in the United States. Am J Epidemiol (2013) 2.30
Effect of spironolactone on left ventricular mass and aortic stiffness in early-stage chronic kidney disease: a randomized controlled trial. J Am Coll Cardiol (2009) 2.30
Effect of modest salt reduction on blood pressure, urinary albumin, and pulse wave velocity in white, black, and Asian mild hypertensives. Hypertension (2009) 2.29
Risk of microalbuminuria and progression to macroalbuminuria in a cohort with childhood onset type 1 diabetes: prospective observational study. BMJ (2008) 2.25
B-type natriuretic peptide (BNP) and amino-terminal proBNP in patients with CKD: relationship to renal function and left ventricular hypertrophy. Am J Kidney Dis (2005) 2.24
Role of N-terminal brain natriuretic peptide (N-TproBNP) in scleroderma-associated pulmonary arterial hypertension. Eur Heart J (2006) 2.16
New-onset diabetes after transplantation: a threat to graft and patient survival. Lancet (2005) 2.11
Synthesis of 1,25-dihydroxyvitamin D(3) by human endothelial cells is regulated by inflammatory cytokines: a novel autocrine determinant of vascular cell adhesion. J Am Soc Nephrol (2002) 2.02
Lack of effect of lowering LDL cholesterol on cancer: meta-analysis of individual data from 175,000 people in 27 randomised trials of statin therapy. PLoS One (2012) 1.93
Pulse versus daily oral cyclophosphamide for induction of remission in ANCA-associated vasculitis: long-term follow-up. Ann Rheum Dis (2011) 1.88
Cholesterol and the risk of renal dysfunction in apparently healthy men. J Am Soc Nephrol (2003) 1.87
Different methods of creatinine measurement significantly affect MELD scores. Liver Transpl (2007) 1.87
Variability of parathyroid hormone and other markers of bone mineral metabolism in patients receiving hemodialysis. Clin J Am Soc Nephrol (2010) 1.85
PTH--a particularly tricky hormone: why measure it at all in kidney patients? Clin J Am Soc Nephrol (2012) 1.77
Inflammation, endothelial dysfunction, and platelet activation in patients with chronic kidney disease: the chronic renal impairment in Birmingham (CRIB) study. Am J Kidney Dis (2004) 1.76
Antiplatelet drugs: American College of Chest Physicians Evidence-Based Clinical Practice Guidelines (8th Edition). Chest (2008) 1.74
Susceptibility of glomerular filtration rate estimations to variations in creatinine methodology: a study in older patients. Ann Clin Biochem (2005) 1.74
Anticoagulants in heart disease: current status and perspectives. Eur Heart J (2007) 1.73
Does the ID-MS traceable MDRD equation work and is it suitable for use with compensated Jaffe and enzymatic creatinine assays? Nephrol Dial Transplant (2006) 1.72
Low IGF-I and elevated testosterone during puberty in subjects with type 1 diabetes developing microalbuminuria in comparison to normoalbuminuric control subjects: the Oxford Regional Prospective Study. Diabetes Care (2003) 1.68
Cardiovascular effects of sevelamer in stage 3 CKD. J Am Soc Nephrol (2013) 1.66
Relationship of serum cystatin C to peritoneal and renal clearance measures in peritoneal dialysis: a cross-sectional study. Am J Kidney Dis (2008) 1.66
Prevalence and risk factors for pulmonary arterial hypertension in patients with lupus. Rheumatology (Oxford) (2009) 1.65
EPA and DHA reduce LPS-induced inflammation responses in HK-2 cells: evidence for a PPAR-gamma-dependent mechanism. Kidney Int (2005) 1.64
Accuracy of the MDRD (Modification of Diet in Renal Disease) study and CKD-EPI (CKD Epidemiology Collaboration) equations for estimation of GFR in the elderly. Am J Kidney Dis (2012) 1.57
The haemodynamic effects of adjunctive hormone therapy in potential heart donors: a prospective randomized double-blind factorially designed controlled trial. Eur Heart J (2009) 1.54
Does urinary tract infection cause proteinuria or microalbuminuria? A systematic review. Nephrol Dial Transplant (2006) 1.53
An appeal to medical journal editors: the need for a full description of laboratory methods and specimen handling in clinical study reports. Clin Chim Acta (2012) 1.51
Telomeres are shorter in myocardial infarction patients compared to healthy subjects: correlation with environmental risk factors. J Mol Med (Berl) (2010) 1.51
An appeal to medical journal editors: the need for a full description of laboratory methods and specimen handling in clinical study reports. Transfusion (2012) 1.50
The influence of a cooked-meat meal on estimated glomerular filtration rate. Ann Clin Biochem (2007) 1.49
Cardiac troponin T circulates in the free, intact form in patients with kidney failure. Clin Chem (2006) 1.49
Fish consumption and prostate cancer risk: a review and meta-analysis. Am J Clin Nutr (2010) 1.48
3-year follow-up of 100 consecutive coronary bifurcation lesions treated with Taxus stents and the crush technique. Catheter Cardiovasc Interv (2010) 1.44
Reducing mortality in myocardial infarction. BMJ (2005) 1.44
Echocardiography in the potential heart donor. Transplantation (2010) 1.41
Spurious hypernatraemia and Citra-Lock. Ann Clin Biochem (2007) 1.41
Salt wars. Nephrol Dial Transplant (2008) 1.40
Kissing drug eluting balloons for in-stent restenosis complicating bifurcations treated with drug-eluting stents. Catheter Cardiovasc Interv (2012) 1.40
The relationship between microalbuminuria and glomerular filtration rate in young type 1 diabetic subjects: The Oxford Regional Prospective Study. Kidney Int (2005) 1.40
Creatine deficiency syndromes: diagnostic pearls and pitfalls. Can J Neurol Sci (2011) 1.38
Effects of nitroglycerin treatment on cardiac autonomic control in heart failure. Clin Auton Res (2004) 1.38
Vitamin K antagonists in heart disease: current status and perspectives (Section III). Position paper of the ESC Working Group on Thrombosis--Task Force on Anticoagulants in Heart Disease. Thromb Haemost (2013) 1.36
Evaluation of Cinacalcet Therapy to Lower Cardiovascular Events (EVOLVE): rationale and design overview. Clin J Am Soc Nephrol (2007) 1.34
Expert consensus document on the use of antiplatelet agents. The task force on the use of antiplatelet agents in patients with atherosclerotic cardiovascular disease of the European society of cardiology. Eur Heart J (2004) 1.34
Specificity characteristics of 7 commercial creatinine measurement procedures by enzymatic and Jaffe method principles. Clin Chem (2011) 1.32
The challenge of secondary prevention for coronary heart disease in older patients: findings from the British Women's Heart and Health Study and the British Regional Heart Study. Fam Pract (2004) 1.32
The second United Kingdom Heart and Renal Protection (UK-HARP-II) Study: a randomized controlled study of the biochemical safety and efficacy of adding ezetimibe to simvastatin as initial therapy among patients with CKD. Am J Kidney Dis (2006) 1.31
Arterial stiffness in chronic kidney disease: causes and consequences. Heart (2010) 1.29
Comparison of two expert-based assessments of diesel exhaust exposure in a case-control study: programmable decision rules versus expert review of individual jobs. Occup Environ Med (2012) 1.25
Prospective study of ultraviolet radiation exposure and risk of cancer in the United States. Int J Cancer (2012) 1.23
Antiplatelet agents for the treatment and prevention of atherothrombosis. Eur Heart J (2011) 1.23
N-terminal Pro-B-type natriuretic peptide, vascular disease risk, and cholesterol reduction among 20,536 patients in the MRC/BHF heart protection study. J Am Coll Cardiol (2007) 1.22
Biomarkers of inflammation predict both vascular and non-vascular mortality in older men. Eur Heart J (2008) 1.22
Cardiac troponins and renal function in nondialysis patients with chronic kidney disease. Clin Chem (2005) 1.21
Effects of potassium chloride and potassium bicarbonate on endothelial function, cardiovascular risk factors, and bone turnover in mild hypertensives. Hypertension (2010) 1.20
Hyponatraemia and hyperkalaemia are more frequent in renal transplant recipients treated with tacrolimus than with cyclosporin. Further evidence for differences between cyclosporin and tacrolimus nephrotoxicities. Nephrol Dial Transplant (2004) 1.20
Mechanisms of dysregulation of low-density lipoprotein receptor expression in vascular smooth muscle cells by inflammatory cytokines. Arterioscler Thromb Vasc Biol (2006) 1.16
Quantification of hemoglobin A2 by tandem mass spectrometry. Clin Chem (2007) 1.16